Skip to content
Independent analysis of NHS open data
PharmaInsight

Relugolix 120mg tablets

0803042X0AAAAAA · Malignant Disease and Immunosuppression
Data updated May 2026
8,817items

Dispensed in May 2026

NHSBSA Prescription Cost Analysis

£919,712

Net ingredient cost · May 2026

NHSBSA PCA

43,335items

Dispensed in the last 12 months

NHSBSA PCA

Figure 1. Relugolix 120mg tablets: national items dispensed by month

0 4k 9k Jul 2025 Sep 2025 Nov 2025 Jan 2026 Mar 2026 May 2026 8,817 Jul 2025: 637 Aug 2025: 1k Sep 2025: 1k Oct 2025: 2k Nov 2025: 2k Dec 2025: 3k Jan 2026: 3k Feb 2026: 6k Mar 2026: 7k Apr 2026: 7k May 2026: 9k

Source: NHSBSA Prescription Cost Analysis, to May 2026

One presentation of Relugolix. See the chemical for the full national picture and related presentations.

Top dispensing practices

Dispensing GP practices supplying this presentation, by items (a subset of national dispensing).